Innate immune escape by Dengue and West Nile viruses

Current Opinion in Virology

Volumn 20, Issue , 2016, Pages 119-128

  Gack, Michaela U ^a   Diamond, Michael S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA BETA INTERFERON RECEPTOR; INTERFERON; VIRUS RNA;

DENGUE; DENGUE VIRUS; HUMAN; INNATE IMMUNITY; INTERFERON INDUCTION; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; WEST NILE FEVER; WEST NILE VIRUS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM;

DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON TYPE I; WEST NILE VIRUS;

EID: 84992512259     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2016.09.013     Document Type: Review

References (91)

1. 1 Halstead, S.B., Dengue. Lancet 370 (2007), 1644–1652.
2. 2 Guzman, M.G., Alvarez, M., Halstead, S.B., Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158 (2013), 1445–1459.
3. 3 Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Brownstein, J.S., Hoen, A.G., Sankoh, O., et al. The global distribution and burden of dengue. Nature 496 (2013), 504–507.
4. 4 Hadinegoro, S.R., Arredondo-Garcia, J.L., Capeding, M.R., Deseda, C., Chotpitayasunondh, T., Dietze, R., Muhammad Ismail, H.I., Reynales, H., Limkittikul, K., Rivera-Medina, D.M., et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373 (2015), 1195–1206.
5. 5 Pitisuttithum, P., Bouckenooghe, A., The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection. Expert Rev Vaccines, 2016.
6. 6 Halstead, S.B., Russell, P.K., Response to Hadinegoro et al. Vaccine, 34, 2016, 4275.
7. 7 Halstead, S.B., Russell, P.K., Protective and immunological behavior of chimeric yellow fever dengue vaccine. Vaccine 34 (2016), 1643–1647.
8. 8 Petersen, L.R., Carson, P.J., Biggerstaff, B.J., Custer, B., Borchardt, S.M., Busch, M.P., Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 141 (2013), 591–595.
9. 9 Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol 14 (2016), 360–373.
10. 10 Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
11. 11 Suthar, M.S., Diamond, M.S., Gale, M. Jr., West Nile virus infection and immunity. Nat Rev Microbiol 11 (2013), 115–128.
12. 12 Green, A.M., Beatty, P.R., Hadjilaou, A., Harris, E., Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol 426 (2014), 1148–1160.
13. 13 Kumar, M., Belcaid, M., Nerurkar, V.R., Identification of host genes leading to West Nile virus encephalitis in mice brain using RNA-seq analysis. Sci Rep, 6, 2016, 26350.
14. 14 Bruns, A.M., Horvath, C.M., LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Cytokine 74 (2015), 198–206.
15. 15 Schlee, M., Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 218 (2013), 1322–1335.
16. 16 Kell, A.M., Gale, M. Jr., RIG-I in RNA virus recognition. Virology 479-480 (2015), 110–121.
17. 17 Suthar, M.S., Ma, D.Y., Thomas, S., Lund, J.M., Zhang, N., Daffis, S., Rudensky, A.Y., Bevan, M.J., Clark, E.A., Kaja, M.K., et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog, 6, 2010, e1000757.
18. 18 Errett, J.S., Suthar, M.S., McMillan, A., Diamond, M.S., Gale, M. Jr., The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol 87 (2013), 11416–11425.
19. 19 Lazear, H.M., Pinto, A.K., Ramos, H.J., Vick, S.C., Shrestha, B., Suthar, M.S., Gale, M. Jr., Diamond, M.S., Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system. J Virol 87 (2013), 11401–11415.
20. 20 Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M.A., García-Sastre, A., Katze, M.G., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82 (2008), 335–345.
21. 21 Nasirudeen, A.M., Wong, H.H., Thien, P., Xu, S., Lam, K.P., Liu, D.X., RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis, 5, 2011, e926.
22. 22 Fredericksen, B.L., Keller, B.C., Fornek, J., Katze, M.G., Gale, M. Jr., Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82 (2008), 609–616.
23. 23 Roby, J.A., Pijlman, G.P., Wilusz, J., Khromykh, A.A., Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses. Viruses 6 (2014), 404–427.
24. 24 Sparrer, K.M., Gack, M.U., Intracellular detection of viral nucleic acids. Curr Opin Microbiol 26 (2015), 1–9.
25. 25 Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., Simon, V., et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog, 8, 2012, e1002934.
26. 26 Yu, C.Y., Chang, T.H., Liang, J.J., Chiang, R.L., Lee, Y.L., Liao, C.L., Lin, Y.L., Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog, 8, 2012, e1002780.
27. 27•• Schoggins, J.W., MacDuff, D.A., Imanaka, N., Gainey, M.D., Shrestha, B., Eitson, J.L., Mar, K.B., Richardson, R.B., Ratushny, A.V., Litvak, V., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505 (2014), 691–695 The authors screened a library of more than 350 human ISGs for effects on 14 viruses and identified 47 genes that inhibit one or more viruses. They further show that the cytosolic DNA sensor cGAS potently restricts not only DNA viruses, but also positive-sense RNA viruses including flaviviruses.
28. 28 Schoggins, J.W., Wilson, S.J., Panis, M., Murphy, M.Y., Jones, C.T., Bieniasz, P., Rice, C.M., A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472 (2011), 481–485.
29. 29 You, F., Wang, P., Yang, L., Yang, G., Zhao, Y.O., Qian, F., Walker, W., Sutton, R., Montgomery, R., Lin, R., et al. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol 14 (2013), 1237–1246.
30. 30 White, M.J., McArthur, K., Metcalf, D., Lane, R.M., Cambier, J.C., Herold, M.J., van Delft, M.F., Bedoui, S., Lessene, G., Ritchie, M.E., et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159 (2014), 1549–1562.
31. 31 Rongvaux, A., Jackson, R., Harman, C.C., Li, T., West, A.P., de Zoete, M.R., Wu, Y., Yordy, B., Lakhani, S.A., Kuan, C.Y., et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159 (2014), 1563–1577.
32. 32 West, A.P., Khoury-Hanold, W., Staron, M., Tal, M.C., Pineda, C.M., Lang, S.M., Bestwick, M., Duguay, B.A., Raimundo, N., MacDuff, D.A., et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520 (2015), 553–557.
33. 33 Holm, C.K., Jensen, S.B., Jakobsen, M.R., Cheshenko, N., Horan, K.A., Moeller, H.B., Gonzalez-Dosal, R., Rasmussen, S.B., Christensen, M.H., Yarovinsky, T.O., et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 13 (2012), 737–743.
34. 34•• Lazear, H.M., Lancaster, A., Wilkins, C., Suthar, M.S., Huang, A., Vick, S.C., Clepper, L., Thackray, L., Brassil, M.M., Virgin, H.W., et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog, 9, 2013, e1003118 The authors establish IRF3, IRF5, and IRF7 as the key transcription factors responsible for type I IFN and ISG induction in myeloid dendritic cells during WNV infection and suggest a novel signaling link between MAVS and IRF5.
35. 35 Chiang, J.J., Davis, M.E., Gack, M.U., Regulation of RIG-I-like receptor signaling by host and viral proteins. Cytokine Growth Factor Rev, 2014.
36. 36 Schoggins, J.W., Dorner, M., Feulner, M., Imanaka, N., Murphy, M.Y., Ploss, A., Rice, C.M., Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A 109 (2012), 14610–14615.
37. 37 Jiang, D., Weidner, J.M., Qing, M., Pan, X.B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P.Y., et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84 (2010), 8332–8341.
38. 38 Li, J., Ding, S.C., Cho, H., Chung, B.C., Gale, M. Jr., Chanda, S.K., Diamond, M.S., A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. MBio, 4, 2013 e00385-00313.
39. 39 Lucas, T.M., Richner, J.M., Diamond, M.S., The Interferon-stimulated gene Ifi27l2a restricts West Nile virus infection and pathogenesis in a cell-type and region-specific manner. J Virol, 2015.
40. 40 Shresta, S., Kyle, J.L., Snider, H.M., Basavapatna, M., Beatty, P.R., Harris, E., Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78 (2004), 2701–2710.
41. 41 Diamond, M.S., Roberts, T.G., Edgil, D., Lu, B., Ernst, J., Harris, E., Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74 (2000), 4957–4966.
42. 42 Samuel, M.A., Diamond, M.S., Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79 (2005), 13350–13361.
43. 43 Chan-Tack, K.M., Forrest, G., Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand J Infect Dis 37 (2005), 944–946.
44. 44 Daffis, S., Samuel, M.A., Suthar, M.S., Keller, B.C., Gale, M. Jr., Diamond, M.S., Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82 (2008), 8465–8475.
45. 45 Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C.K., Walther, P., Fuller, S.D., Antony, C., Krijnse-Locker, J., Bartenschlager, R., Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5 (2009), 365–375.
46. 46 Junjhon, J., Pennington, J.G., Edwards, T.J., Perera, R., Lanman, J., Kuhn, R.J., Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J Virol 88 (2014), 4687–4697.
47. 47 den Boon, J.A., Ahlquist, P., Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories. Annu Rev Microbiol 64 (2010), 241–256.
48. 48 Gillespie, L.K., Hoenen, A., Morgan, G., Mackenzie, J.M., The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol 84 (2010), 10438–10447.
49. 49 Uchida, L., Espada-Murao, L.A., Takamatsu, Y., Okamoto, K., Hayasaka, D., Yu, F., Nabeshima, T., Buerano, C.C., Morita, K., The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response. Sci Rep, 4, 2014, 7395.
50. 50 Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.Y., Schneller, S., Zust, R., Dong, H., et al. 2’-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456.
51. 51 Zust, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W., Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S., et al. Ribose 2’-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12 (2011), 137–143.
52. 52 Habjan, M., Hubel, P., Lacerda, L., Benda, C., Holze, C., Eberl, C.H., Mann, A., Kindler, E., Gil-Cruz, C., Ziebuhr, J., et al. Sequestration by IFIT1 impairs translation of 2’O-unmethylated capped RNA. PLoS Pathog, 9, 2013, e1003663.
53. 53 Kimura, T., Katoh, H., Kayama, H., Saiga, H., Okuyama, M., Okamoto, T., Umemoto, E., Matsuura, Y., Yamamoto, M., Takeda, K., Ifit1 inhibits Japanese encephalitis virus replication through binding to 5’ capped 2’-O unmethylated RNA. J Virol 87 (2013), 9997–10003.
54. 54 Szretter, K.J., Daniels, B.P., Cho, H., Gainey, M.D., Yokoyama, W.M., Gale, M. Jr., Virgin, H.W., Klein, R.S., Sen, G.C., Diamond, M.S., 2’-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog, 8, 2012, e1002698.
55. 55 Li, S.H., Dong, H., Li, X.F., Xie, X., Zhao, H., Deng, Y.Q., Wang, X.Y., Ye, Q., Zhu, S.Y., Wang, H.J., et al. Rational design of a flavivirus vaccine by abolishing viral RNA 2’-O methylation. J Virol 87 (2013), 5812–5819.
56. 56 Zust, R., Dong, H., Li, X.F., Chang, D.C., Zhang, B., Balakrishnan, T., Toh, Y.X., Jiang, T., Li, S.H., Deng, Y.Q., et al. Rational design of a live attenuated dengue vaccine: 2’-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques. PLoS Pathog, 9, 2013, e1003521.
57. 57 Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007), 916–920.
58. 58 Gack, M.U., Kirchhofer, A., Shin, Y.C., Inn, K.S., Liang, C., Cui, S., Myong, S., Ha, T., Hopfner, K.P., Jung, J.U., Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A 105 (2008), 16743–16748.
59. 59 Peisley, A., Wu, B., Xu, H., Chen, Z.J., Hur, S., Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509 (2014), 110–114.
60. 60 Pauli, E.K., Chan, Y.K., Davis, M.E., Gableske, S., Wang, M.K., Feister, K.F., Gack, M.U., The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci Signal, 7, 2014, ra3.
61. 61 Schuessler, A., Funk, A., Lazear, H.M., Cooper, D.A., Torres, S., Daffis, S., Jha, B.K., Kumagai, Y., Takeuchi, O., Hertzog, P., et al. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol 86 (2012), 5708–5718.
62. 62 Pijlman, G.P., Funk, A., Kondratieva, N., Leung, J., Torres, S., van der Aa, L., Liu, W.J., Palmenberg, A.C., Shi, P.Y., Hall, R.A., et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4 (2008), 579–591.
63. 63• Manokaran, G., Finol, E., Wang, C., Gunaratne, J., Bahl, J., Ong, E.Z., Tan, H.C., Sessions, O.M., Ward, A.M., Gubler, D.J., et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350 (2015), 217–221 This study shows that the sfRNA from an epidemic strain of DENV binds to and inhibits TRIM25 deubiquitination, thereby dampening RIG-I-mediated IFN induction.
64. 64 Liu, H.M., Loo, Y.M., Horner, S.M., Zornetzer, G.A., Katze, M.G., Gale, M. Jr., The Mitochondrial Targeting Chaperone 14-3-3epsilon Regulates a RIG-I Translocon that Mediates Membrane Association and Innate Antiviral Immunity. Cell Host Microbe 11 (2012), 528–537.
65. 65•• Chan, Y.K., Gack, M.U., A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol 17 (2016), 523–530 The authors establish that the NS3 protein of DENV and WNV interacts with 14-3-3ɛ to prevent RIG-I translocation to mitochondria, thereby suppressing IFN gene expression. They further show that NS3 mimics a conventional phosphorylation motif of cellular 14-3-3-binding partners to interact with 14-3-3ɛ and inhibit RIG-I signaling.
66. 66 Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., Tschopp, J., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005), 1167–1172.
67. 67 Li, X.D., Sun, L., Seth, R.B., Pineda, G., Chen, Z.J., Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102 (2005), 17717–17722.
68. 68•• Akey, D.L., Brown, W.C., Dutta, S., Konwerski, J., Jose, J., Jurkiw, T.J., DelProposto, J., Ogata, C.M., Skiniotis, G., Kuhn, R.J., et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343 (2014), 881–885 The authors solve the crystal structures for full-length, glycosylated NS1 from WNV and DENV, which reveals that NS1 forms hexamers comprised of three dimers.
69. 69 Anglero-Rodriguez, Y.I., Pantoja, P., Sariol, C.A., Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB kinase epsilon interaction. Clin Vaccine Immunol 21 (2014), 29–38.
70. 70 Dalrymple, N.A., Cimica, V., Mackow, E.R., Dengue virus NS proteins inhibit RIG-I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant. MBio, 6, 2015 e00553-00515.
71. 71 Arjona, A., Ledizet, M., Anthony, K., Bonafe, N., Modis, Y., Town, T., Fikrig, E., West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 179 (2007), 8403–8409.
72. 72 Guo, J.T., Hayashi, J., Seeger, C., West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79 (2005), 1343–1350.
73. 73 Munoz-Jordan, J.L., Laurent-Rolle, M., Ashour, J., Martinez-Sobrido, L., Ashok, M., Lipkin, W.I., Garcia-Sastre, A., Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79 (2005), 8004–8013.
74. 74 Evans, J.D., Seeger, C., Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol 81 (2007), 11809–11816.
75. 75 Keller, B.C., Fredericksen, B.L., Samuel, M.A., Mock, R.E., Mason, P.W., Diamond, M.S., Gale, M. Jr., Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80 (2006), 9424–9434.
76. 76 Mansfield, K.L., Johnson, N., Cosby, S.L., Solomon, T., Fooks, A.R., Transcriptional upregulation of SOCS 1 and suppressors of cytokine signaling 3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA after infection with West Nile virus or tick-borne encephalitis virus. Vector Borne Zoonotic Dis 10 (2010), 649–653.
77. 77• Bhattacharyya, S., Zagorska, A., Lew, E.D., Shrestha, B., Rothlin, C.V., Naughton, J., Diamond, M.S., Lemke, G., Young, J.A., Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14 (2013), 136–147 This study shows that several enveloped viruses including WNV bind to and activate TAM receptors on dendritic cells, thereby dampening type I IFN signaling.
78. 78 Mackenzie, J.M., Khromykh, A.A., Parton, R.G., Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2 (2007), 229–239.
79. 79 Evans, J.D., Crown, R.A., Sohn, J.A., Seeger, C., West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol 24 (2011), 253–263.
80. 80 Liu, W.J., Wang, X.J., Mokhonov, V.V., Shi, P.Y., Randall, R., Khromykh, A.A., Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79 (2005), 1934–1942.
81. 81 Ashour, J., Laurent-Rolle, M., Shi, P.Y., Garcia-Sastre, A., NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83 (2009), 5408–5418.
82. 82 Mazzon, M., Jones, M., Davidson, A., Chain, B., Jacobs, M., Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200 (2009), 1261–1270.
83. 83 Laurent-Rolle, M., Boer, E.F., Lubick, K.J., Wolfinbarger, J.B., Carmody, A.B., Rockx, B., Liu, W., Ashour, J., Shupert, W.L., Holbrook, M.R., et al. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 84 (2010), 3503–3515.
84. 84 Morrison, J., Laurent-Rolle, M., Maestre, A.M., Rajsbaum, R., Pisanelli, G., Simon, V., Mulder, L.C., Fernandez-Sesma, A., Garcia-Sastre, A., Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog, 9, 2013, e1003265.
85. 85 Ashour, J., Morrison, J., Laurent-Rolle, M., Belicha-Villanueva, A., Plumlee, C.R., Bernal-Rubio, D., Williams, K.L., Harris, E., Fernandez-Sesma, A., Schindler, C., et al. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 8 (2010), 410–421.
86. 86 Suthar, M.S., Brassil, M.M., Blahnik, G., Gale, M. Jr., Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar. J Virol 86 (2012), 7704–7709.
87. 87•• Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe 19 (2016), 720–730 The authors evaluate infection and pathogenesis with contemporary and historical ZIKV strains in immunocompetent mice and mice lacking key molecules of the IFN response, and show that Ifnar1 or Irf3/5/7 knockout mice develop neurological disease and succumb to ZIKV infection.
88. 88•• Miner, J.J., Cao, B., Govero, J., Smith, A.M., Fernandez, E., Cabrera, O.H., Garber, C., Noll, M., Klein, R.S., Noguchi, K.K., et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165 (2016), 1081–1091 This study establishes two mouse models of in utero transmission and fetal disease associated with ZIKV infection, which may facilitate future studies to test therapies and vaccines to prevent congenital malformations.
89. 89• Grant, A., Ponia, S.S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M.C., Sanchez-Seco, M.P., Evans, M.J., Best, S.M., et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe, 2016 This paper demonstrates that the NS5 protein of ZIKV induces the proteasomal degradation of the transcriptional activator STAT2. This mechanism functions for human but not mouse STAT2, which in part, could explain species restriction of ZIKV.
90. 90 Liu, W.J., Chen, H.B., Wang, X.J., Huang, H., Khromykh, A.A., Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78 (2004), 12225–12235.
91. 91 Liu, W.J., Wang, X.J., Clark, D.C., Lobigs, M., Hall, R.A., Khromykh, A.A., A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 80 (2006), 2396–2404.